Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-086259
Filing Date
2025-06-13
Accepted
2025-06-13 16:30:45
Documents
7
Effectiveness Date
2025-06-13

Document Format Files

Seq Description Document Type Size
1 S-8 rgnx-20250613.htm S-8 116080
2 EX-5.1 rgnx-ex5_1.htm EX-5.1 9527
3 EX-23.1 rgnx-ex23_1.htm EX-23.1 3018
4 EX-99.1 rgnx-ex99_1.htm EX-99.1 259429
5 EX-FILING FEES rgnx-exfiling_fees.htm EX-FILING FEES 32674
6 GRAPHIC img252287865_0.jpg GRAPHIC 11967
7 GRAPHIC img252287865_1.jpg GRAPHIC 8606
  Complete submission text file 0000950170-25-086259.txt   450554
Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

EIN.: 471851754 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288040 | Film No.: 251047105
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)